Next |
home / stock / ensc / ensc message board
Subject | By | Source | When |
---|---|---|---|
nsysce Biosciences Announces Successful Completion of Ground-Breaking Study | subslover | investorshub | 05/09/2023 1:27:57 PM |
Time for a bounce? | PennyPusher786 | investorshub | 05/04/2023 7:09:57 PM |
$ENSC great article | PennyPusher786 | investorshub | 05/04/2023 3:41:14 PM |
news out | Shift-4 | investorshub | 04/30/2023 8:47:52 PM |
should we be shorting? | Hercules1 | investorshub | 04/29/2023 5:04:07 PM |
where is the squeeze? | Nathan123456 | investorshub | 04/29/2023 1:40:55 AM |
good read | surf1944 | investorshub | 04/26/2023 6:14:44 PM |
great news | PennyPusher786 | investorshub | 04/21/2023 1:02:52 PM |
$ENSC where is the squeeze? | PennyPusher786 | investorshub | 04/21/2023 1:09:37 AM |
$ENSC The gaining | surf1944 | investorshub | 04/20/2023 2:04:39 AM |
The gaining last up | 81vette | investorshub | 04/19/2023 10:15:15 PM |
$ENSC short squeeze article | Invest-in-America | investorshub | 04/18/2023 7:24:57 PM |
$ENSC great article | dennisv | investorshub | 04/13/2023 7:32:39 PM |
$ENSC The trading up | 2times2 | investorshub | 04/13/2023 1:47:27 AM |
$ENSC Good read | PennyPusher786 | investorshub | 04/11/2023 3:34:51 PM |
ENSC Ensysce Biosciences | MiamiGent | investorshub | 03/23/2023 2:26:27 AM |
This is by far the most manipulated ticker | Shift-4 | investorshub | 03/22/2023 3:13:23 PM |
$ENSC Took a stab at .68 | MiamiGent | investorshub | 03/16/2023 6:22:41 PM |
Ensysce Biosciences | StockLogistics | investorshub | 03/16/2023 11:40:04 AM |
appreciated! Minimum just 1$ pps. Revisited in June | 2times2 | investorshub | 03/10/2023 8:10:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc. Company Name:
ENSC Stock Symbol:
NASDAQ Market:
Corporate Update Call to be Held Thursday, March 21, 2024 at 11:00am ET to Discuss Recent FDA Breakthrough Therapy Designation and Phase 3 Clinical Plans SAN DIEGO, CA / ACCESSWIRE / March 15, 2024 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage compa...